These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1357425)
21. Efficacy of beta blockers in the management of problem behaviours in people with intellectual disabilities: a systematic review. Ward F; Tharian P; Roy M; Deb S; Unwin GL Res Dev Disabil; 2013 Dec; 34(12):4293-303. PubMed ID: 24171827 [TBL] [Abstract][Full Text] [Related]
22. Stress and self-injurious behavior; hormonal and serotonergic parameters in mentally retarded subjects. Verhoeven WM; Tuinier S; van den Berg YW; Coppus AM; Fekkes D; Pepplinkhuizen L; Thijssen JH Pharmacopsychiatry; 1999 Jan; 32(1):13-20. PubMed ID: 10071178 [TBL] [Abstract][Full Text] [Related]
23. The use of clozapine in a mentally retarded and aggressive population. Cohen SA; Underwood MT J Clin Psychiatry; 1994 Oct; 55(10):440-4. PubMed ID: 7961521 [TBL] [Abstract][Full Text] [Related]
24. Challenging behavior in adults with epilepsy and intellectual disability: An analysis of epilepsy characteristics. van Ool JS; Snoeijen-Schouwenaars FM; Tan IY; Jurgen Schelhaas H; Aldenkamp AP; Hendriksen JGM Epilepsy Behav; 2018 Sep; 86():72-78. PubMed ID: 30153936 [TBL] [Abstract][Full Text] [Related]
25. Behaviour Problems in Children with Intellectual Disabilities in a Resource-Poor Setting in India - Part 1: Association with Age, Sex, Severity of Intellectual Disabilities and IQ. Lakhan R; Kishore MT J Appl Res Intellect Disabil; 2018 Jan; 31(1):43-50. PubMed ID: 27457025 [TBL] [Abstract][Full Text] [Related]
26. A quasi-experimental study on the effect of electrical aversion treatment on imposed mechanical restraint for severe self-injurious behavior. Duker PC; Seys DM Res Dev Disabil; 2000; 21(4):235-42. PubMed ID: 10983780 [TBL] [Abstract][Full Text] [Related]
27. Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation. Davanzo PA; King BH J Child Adolesc Psychopharmacol; 1996; 6(4):273-9. PubMed ID: 9231320 [TBL] [Abstract][Full Text] [Related]
28. Eltoprazine for aggression in schizophrenia and mental retardation. Tiihonen J; Hakola P; Paanila J; Turtiainen M Lancet; 1993 Jan; 341(8840):307. PubMed ID: 8093942 [No Abstract] [Full Text] [Related]
29. The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine. Curtis AR; Richards RW Ann Clin Psychiatry; 2007; 19(3):199-200. PubMed ID: 17729023 [No Abstract] [Full Text] [Related]
30. [The neuroendocrinological examinations in mentally retarded boy with self-injurious behavior (SIB) and the effect of naloxone, clomipramine and sulpiride on SIB]. Sugama S; Kusano K; Okazaki M; Eto Y Rinsho Shinkeigaku; 1992 Aug; 32(8):890-2. PubMed ID: 1490319 [TBL] [Abstract][Full Text] [Related]
31. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. Valicenti-McDermott MR; Demb H J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544 [TBL] [Abstract][Full Text] [Related]
32. Self-abusive behavior in the mentally retarded. Lemke H Am J Occup Ther; 1974 Feb; 28(2):94-8. PubMed ID: 4811361 [No Abstract] [Full Text] [Related]
33. Self-injurious behaviours in people with and without intellectual delay: implications for the genetics of suicide. Ernst C; Morton CC; Gusella JF Int J Neuropsychopharmacol; 2010 May; 13(4):527-8. PubMed ID: 19887018 [TBL] [Abstract][Full Text] [Related]
34. Self-injury in people with learning disabilities. Morgan J; Mackay D Nurs Stand; 1998 Mar 18-24; 12(26):39-42. PubMed ID: 9697514 [No Abstract] [Full Text] [Related]
35. Addendum to P. L. Baldi (1998). Baldi PL Psychol Rep; 2003 Dec; 93(3 Pt 1):717-8. PubMed ID: 14723434 [TBL] [Abstract][Full Text] [Related]
36. Functional properties of behaviour problems depending on level of intellectual disability. Medeiros K; Rojahn J; Moore LL; van Ingen DJ J Intellect Disabil Res; 2014 Feb; 58(2):151-61. PubMed ID: 23464786 [TBL] [Abstract][Full Text] [Related]
37. Improvement of Self-Injury With Dopamine and Serotonin Replacement Therapy in a Patient With a Hemizygous PAK3 Mutation: A New Therapeutic Strategy for Neuropsychiatric Features of an Intellectual Disability Syndrome. Horvath GA; Tarailo-Graovac M; Bartel T; Race S; Van Allen MI; Blydt-Hansen I; Ross CJ; Wasserman WW; Connolly MB; van Karnebeek CDM J Child Neurol; 2018 Jan; 33(1):106-113. PubMed ID: 29246092 [TBL] [Abstract][Full Text] [Related]
38. Pseudodementia in the mentally retarded. A case report and review. Myers BA; Pueschel SM Clin Pediatr (Phila); 1987 May; 26(5):275-7. PubMed ID: 3568533 [TBL] [Abstract][Full Text] [Related]
39. Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo- and baseline-controlled multi-centre study. The Eltoprazine Aggression Research Group. de Koning P; Mak M; de Vries MH; Allsopp LF; Stevens RB; Verbruggen R; Van den Borre R; van Peteghem P; Kohen D; Arumainayagam M Int Clin Psychopharmacol; 1994 Sep; 9(3):187-94. PubMed ID: 7814828 [TBL] [Abstract][Full Text] [Related]
40. Self-injurious, aggressive and destructive behaviour in children with severe intellectual disability: Prevalence, service need and service receipt in the UK. Ruddick L; Davies L; Bacarese-Hamilton M; Oliver C Res Dev Disabil; 2015; 45-46():307-15. PubMed ID: 26296078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]